Lab Corp. (LH) Tops Q2 EPS by 54c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Labcorp Announces 2021 Second Quarter Results
July 29, 2021 7:01 AM EDTCompany Raises Full Year Guidance
Revenue: Q2 of $3.8 billion, versus $2.8 billion last year Diluted EPS: Q2 of $4.76, versus $2.37 last year Adjusted EPS: Q2 of $6.13, versus $2.57 last year Free Cash Flow: Q2 of $390 million, versus $272 million last year Acquired remaining ownership interest in OmniSeq, bolstering oncology portfolio Agreed to purchase the outreach laboratory business of a Minnesota-based hospital Full Year 2021 Guidance: Revenue raised to range of 6.5% to 9.0%; Adjusted EPS raised to range of $21.50 to $25.00; Free Cash Flow raised to range of $1.95 billion to $2.15... More
